Brief: Pelthos Therapeutics Announces CFO Transition
10/04/2026 22:00
April 10 (Reuters) - Pelthos Therapeutics Inc PTHS.A: PELTHOS THERAPEUTICS ANNOUNCES CFO TRANSITION PELTHOS THERAPEUTICS INC - APPOINTS JOHN M. GAY AS CFO EFFECTIVE APRIL 10, 2026 Source text: ID:nGNX3PTTXN Further company coverage: PTHS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pelthos Therapeutics
See all newsPelthos Therapeutics falls as co says will restate Q1 financial statements
Brief: Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoption
Brief: Pelthos Therapeutics Announces CFO Transition
Brief: Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain